ADAP
Adaptimmune Therapeutics
ADAP
ADAP
Delisted
ADAP was delisted on the 27th of October, 2025.
40 hedge funds and large institutions have $121M invested in Adaptimmune Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
40
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$489K | |
| 2 | +$472K | |
| 3 | +$418K | |
| 4 |
AG
Artal Group
Luxembourg
|
+$405K |
| 5 |
AA
ALPS Advisors
Denver,
Colorado
|
+$275K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$2.52M | |
| 3 | -$810K | |
| 4 |
RG
Rathbones Group
Liverpool,
United Kingdom
|
-$525K |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$488K |